AFI Research Funding

Cross Border Grants

Cross Border Grants facilitate international collaboration between researchers in the field of Alzheimer’s and dementia research.

Researchers can apply for up to €200,000 for a period of two years.
Funding is awarded to projects that significantly advance our understanding of Alzheimer’s disease or related dementias in the fields of basic research, diagnostics, prevention and therapy.
Applications must be submitted jointly by a researcher from Germany and a researcher from another country. The partner researcher will be funded by Alzheimer Nederland (Netherlands), Fondation Vaincre Alzheimer (France), or the BrightFocus Foundation (worldwide – see guidelines).
For more details, please refer to the guidelines on this page.

Applications must be submitted via the AIMS application platform.

Questions about the application process or funding conditions? Please see our FAQ for Scientists.

Your contact

Dr. Anne Pfitzer-Bilsing Leiterin Wissenschaft

Dr. Anne Pfitzer-Bilsing
Director of Scientific Affairs

Tel.: 0211 - 86 20 66 14
E-Mail

Schedule - Cross Border Grants

Call for Application: January 4^th, 2027
Deadline Letter of Intent: February 1^st, 2027, 13:00 CET
Review by European Scientific Advisory Board: ongoing
Notification to applicants regarding the request for a full application: May 2027
Deadline full application: June 21^st, 2027, 13:00 CET
Review by European Scientific Advisory Board and external reviewers: June - October 2027
Notifying applicants of grant awards and denials: November 2027
Start of the project: January 1^st, 2028

Downloads

AFI uses an online application system. Applications (letters of intent) for Cross Border grants can be submitted there in English from January 4^th, 2027.